Covaryx H.S. Oral Tablet 0.625-1.25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Covaryx H.S.: Oral tablet (0.625-1.25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_19368.JPG
Covaryx H.S. 0.625-1.25mg Tab
Centrix Pharmaceutical Inc
Pill Identification: CO20 
Drug Image file DrugItem_19368.JPG
Covaryx H.S. 0.625-1.25mg Tab
Centrix Pharmaceutical Inc
Pill Identification: CO20 

What is this Medicine?

ESTERIFIED ESTROGENS; METHYLTESTOSTERONE (es TAIR i fyed ES troe jenz; meth il tes TOS te rone) is a combination of hormones. This medicine is used to treat some of the symptoms of menopause like hot flashes and vaginal dryness.

CVS Pharmacy Patient Statistics for Covaryx H.S.: Oral tablet(0.625-1.25mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Covaryx H.S. 0.625mg-1.25mg Tablet

NDC: 115280020
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)




Labeled but not FDA approved for the following conditions:
Menopause, Hot Flashes

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Covaryx H.S. 0.625mg-1.25mg Tablet
Drug Image file DrugItem_19368.JPG
Centrix Pharmaceutical Inc
Pill Identification: CO20 
Shape: oblong
Color: pink
Drug Image file DrugItem_10455.JPG
Centrix Pharmaceutical Inc
Pill Identification: CO20 
Shape: oblong
Color: pink

Reported Side Effects for Covaryx H.S. 0.625mg-1.25mg Tablet

Endometrial Hyperplasia Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Menstrual Cramps Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Breakthrough Bleeding Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
No Menstrual Periods Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Covaryx H.S. 0.625mg-1.25mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Minor Lifestyle Interaction
Grapefruit juice and Covaryx H.S. 0.625mg-1.25mg Tablet(Esterified Estrogens)
Grapefruit juice and Estrogens(Esterified Estrogens)
Grapefruit juice and grapefruit-containing foods may increase the side effects of estrogen in some females, such as nausea, breast tenderness, headache or fluid retention. There may be no interaction. Do not significantly change your grapefruit intake while taking estrogens for hormone replacement therapy or as part of hormonal birth control products. Report any unusual side effects, like unusual non-menstrual vaginal bleeding, promptly for evaluation.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Covaryx H.S.

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.